Zeeshan Ahmad

Professor

  • Reader in Pharmaceutical Science (MD) & Royal Society Industry Fellow, Pharmacy
  • Room 2.026, Stopford Building, Oxford Road,

    M13 9PL, Manchester,

    United Kingdom

Accepting PhD Students

PhD projects

Various PhD Projects areas - contact to request further/additional details:                 •Microneedles and other Technologies for Transdermal Drug Delivery • Advancement of  Electrospinning and Electrospraying (EHDA) Technologies • Drug Dosage Design and Formulation of Pharmaceuticals • Engineering and Manufacturing of Novel Drug Delivery Systems (Microfluidics, EHDA, 3D Printing, Micro-Moulding and other Emerging Platform Technologies) • Biomaterials (Wounds, Biomaterial Surfaces, Tissue Engineering) • Immunotherapy and Chemotherapy Technology Advancement• Biomedical/Pharmaceutical Product Design and Development• Drug Delivery using Nanoparticles, Nanofibers and Microbubbles•<br/>

Personal profile

Biography

Zeeshan obtained his first degree (Pharmaceutical Chemistry, with Honours from Queen Mary, University of London) and his PhD (EPSRC Scholarship) from the EPSRC Biomedical Materials IRC (also Queen Mary, University of London). He has held several prestigious Fellowships (EPSRC, The Leverhulme Trust and The Royal Society) and has worked in several Universities (Queen Mary University of London, University College London (UCL), University of Portsmouth, De Montfort University and The University of Manchester) which includes numerous Schools of Pharmacy in the UK.

His research is highly interdisciplinary (Pharmaceutics, Biomaterials, Advanced Engineering, Advanced Materials and Engineering & Manufacturing) with focus on emerging themes. He has an active research group and is currently supervising national and international students (~6 PhD students). To date he has supervised 24 PhD students to successful completion (national and international). Alumni from his research group work across both industry (Pharmaceutical and Healthcare) and Academia (national and international). He has published >200 peer reviewed research outputs and has presented at >300 events.

As well as leading his own research group, he has led a large Pharmaceutical Technology Group (>15 academic staff) with diverse interests cutting across a range of pharmaceutical subject areas (from manufacturing to dosage engineering). He has initiated several recognised initiatives nationally within the field. In addition to receiving national awards and honours, he has developed several technologies which are now available commercially. 

Research interests

Our research group’s interests are:

  • Transdermal Drug Delivery (e.g. Microneedles and other devices) and Wound Healing Technologies
  • Advanced Pharmaceutical Structures Nanoparticles, Nanofibers and Microbubbles
  • Novel Cancer Therapy & Drug Delivery Systems (Advanced Materials & Technologies)
  • Novel Immunotherapies & Dosage Forms
  • 3D Printing of Biomaterials & Drug Delivery Systems
  • Advanced Pharmaceutical Engineering (e.g. Electrospinning, Electrospraying, Microfluidics, 3DP, Micromoulding, Wet Chemical Engineering Design and several others) and Manufacturing (Processes and Scale)
  • Biomaterials, Bio-interfaces & Tissue Engineering
  • Devices & Biomedical Technologies
  • AI, Machine Learning, Robotics and Automation Enhancing existing and emerging drug delivery technologies, materials and models via coupling with emerging computational concepts 

Research articles found on the google scholar link above will provide a better representation (until the groups website is set-up).

My group

Group website to follow shortly. In the meantime, for research areas please scope the groups publications using the google scholar link above (university output repository & SCOPUS is being updated). Updated website will provide further details on reesearch endevours, industry, alumni, products and other scholarly/research/academic activity.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 9 - Industry, Innovation, and Infrastructure
  • SDG 11 - Sustainable Cities and Communities
  • SDG 12 - Responsible Consumption and Production
  • SDG 17 - Partnerships for the Goals

Education/Academic qualification

Doctor of Philosophy, Biomedical Materials - Design, Synthesis and Processing, The University of London

Award Date: 1 Apr 2007

Bachelor of Science, Pharmaceutical Chemistry, Queen Mary University of London

Areas of expertise

  • RS Pharmacy and materia medica
  • Drug Delivery
  • Pharmaceutics
  • Dosage Form Design
  • Nanotechnology
  • Formulation Science
  • Cancer Therapy
  • Immunology
  • Therapeutic response
  • Personalised medicine
  • Solid Dosage Forms
  • Particles
  • TJ Mechanical engineering and machinery
  • Engineering
  • Manufacturing
  • Material design
  • Biomaterials
  • Tissue Engineering
  • 3D Printing
  • Topography
  • Process Engineering
  • Process Control
  • Quality Control techniques

Research Beacons, Institutes and Platforms

  • Advanced materials
  • Biotechnology
  • Cancer
  • Henry Royce Institute
  • Manchester Institute of Innovation Research
  • Manchester Institute of Biotechnology
  • Manchester Cancer Research Centre
  • Healthier Futures
  • National Graphene Institute
  • Christabel Pankhurst Institute

Fingerprint

Dive into the research topics where Zeeshan Ahmad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles